In vivo mouse models of dilated cardiomyopathy treated with SP600125 present a significant reduction in the expression of collagen and fibronectin, thus preventing the progression of cardiac fibrosis [65]. The gene discussed is FN1; the disease is dilated cardiomyopathy.